Largest Swiss (SMI) Pharmaceuticals & Biotech Stocks by Market Cap

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
NOVN Novartis	CHF89.50	4.6%	-1.8%	CHF182.6b	CHF99.16	PE21.9x	E10.0%	3.7%
ROG Roche Holding	CHF221.00	-0.5%	-21.2%	CHF178.2b	CHF279.39	PE15.3x	E8.6%	4.3%
LONN Lonza Group	CHF527.80	5.0%	-4.7%	CHF38.1b	CHF566.00	PE58.2x	E19.9%	0.8%
GALD Galderma Group	CHF66.79	3.4%	n/a	CHF15.9b	n/a	n/a	n/a	n/a
SDZ Sandoz Group	CHF30.00	1.7%	n/a	CHF12.9b	CHF35.21	PE183.2x	E29.7%	1.5%
BANB Bachem Holding	CHF81.10	3.1%	-16.5%	CHF6.1b	CHF70.80	PE54.4x	E15.4%	1.0%
TECN Tecan Group	CHF332.60	-0.2%	-14.2%	CHF4.3b	CHF395.57	PE32.3x	E9.2%	0.9%
SFZN Siegfried Holding	CHF876.00	-1.5%	27.6%	CHF3.8b	CHF1,015.90	PE33.3x	E14.7%	0.4%
DESN Dottikon ES Holding	CHF233.00	1.1%	0.4%	CHF3.2b	n/a	PE37.3x	S11.2%	0%
SKAN SKAN Group	CHF82.00	5.1%	-4.9%	CHF1.8b	CHF91.33	PE70.1x	E34.8%	0.4%
COPN Cosmo Pharmaceuticals	CHF71.60	0.3%	32.8%	CHF1.1b	CHF93.34	PE1025.1x	E30.4%	2.7%
PPGN PolyPeptide Group	CHF29.55	1.9%	31.9%	CHF974.2m	CHF21.55	PS3.1x	E0.07%	0%
BSLN Basilea Pharmaceutica	CHF40.30	-1.1%	-6.7%	CHF483.7m	CHF70.58	PE46.3x	E32.4%	0%
IDIA Idorsia	CHF1.90	-3.6%	-77.9%	CHF339.8m	CHF1.72	PS1.8x	E16.9%	n/a
KURN Kuros Biosciences	CHF6.86	-8.5%	383.1%	CHF252.8m	n/a	PS7.5x	n/a	n/a
XLS Xlife Sciences	CHF34.30	1.2%	4.6%	CHF195.6m	CHF68.00	PE13.1x	n/a	n/a
NWRN Newron Pharmaceuticals	CHF7.28	4.7%	64.0%	CHF135.6m	CHF13.01	PS15.3x	E53.3%	n/a
MOLN Molecular Partners	CHF3.36	-0.3%	-43.7%	CHF110.4m	CHF9.35	PS15.7x	E5.1%	n/a
SANN Santhera Pharmaceuticals Holding	CHF9.50	4.3%	48.0%	CHF87.5m	CHF30.00	PS1.6x	S27.3%	n/a
RLF Relief Therapeutics Holding	CHF1.30	-0.8%	-81.7%	CHF16.3m	n/a	PS2.8x	n/a	n/a
ADXN Addex Therapeutics	CHF0.12	-23.3%	-7.6%	CHF14.8m	n/a	PS9x	E94.0%	n/a
SPEX Spexis	CHF0.059	7.3%	-84.9%	CHF4.0m	n/a	PS3.4x	n/a	n/a
KNRS Kinarus Therapeutics Holding	CHF16.13	5.9%	-66.7%	CHF3.9m	n/a	n/a	n/a	n/a
OBSN ObsEva	CHF0.0088	76.0%	-89.1%	CHF1.0m	n/a	PE0.1x	n/a	n/a